Skip to main content
Top
Published in: Journal of Neurology 11/2017

01-11-2017 | Original Communication

Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience

Authors: Maxens Decavèle, Nicolas Weiss, Isabelle Rivals, Hélène Prodanovic, Ahmed Idbaih, Julien Mayaux, Thomas Similowski, Alexandre Demoule

Published in: Journal of Neurology | Issue 11/2017

Login to get access

Abstract

The purpose of this study is to describe the reasons for ICU admission and to evaluate the outcome and prognostic factors of patients with primary malignant brain tumors (PMBT) admitted to the intensive care unit (ICU). This is a retrospective observational cohort study of 196 PMBT patients admitted to two ICUs over a 19-year period. Acute respiratory failure was the main reason for ICU admission (45%) followed by seizures (25%) and non-epileptic coma (14%). Seizures were more common in patients with glial lesions (84 vs. 67%), whereas patients with primary brain lymphoma were more frequently admitted for shock (42 vs. 18%). Overall ICU and 90-day mortality rates were 23 and 50%, respectively. Admission for seizures was independently associated with lower ICU mortality [odds ratio (OR) 0.06], whereas the need for mechanical ventilation (OR 6.85), cancer progression (OR 7.84), respiratory rate (OR 1.11) and Glasgow coma scale (OR 0.85) were associated with higher ICU mortality. Among the 95 patients who received invasive mechanical ventilation, ICU mortality was 37% (n = 35). For these patients, admission for seizures was associated with lower ICU mortality (OR 0.050) whereas cancer progression (OR 7.49) and respiratory rate (OR 1.08) were associated with higher ICU mortality. The prognosis of PMBT patients admitted to the ICU appears relatively favorable compared to that of hematologic malignancies or solid tumors, especially when the patient is admitted for seizures. The presence of a PMBT, therefore, does not appear to be sufficient for refusal of ICU admission. Predictive factors of mortality may help clinicians make optimal triage decisions.
Literature
1.
go back to reference Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G et al (2010) Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 38:9–15CrossRefPubMed Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G et al (2010) Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 38:9–15CrossRefPubMed
2.
go back to reference Puxty K, McLoone P, Quasim T, Kinsella J, Morrison D (2014) Survival in solid cancer patients following intensive care unit admission. Intensive Care Med 40:1409–1428CrossRefPubMed Puxty K, McLoone P, Quasim T, Kinsella J, Morrison D (2014) Survival in solid cancer patients following intensive care unit admission. Intensive Care Med 40:1409–1428CrossRefPubMed
3.
go back to reference Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B (2011) Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 1:5CrossRefPubMedPubMedCentral Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B (2011) Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 1:5CrossRefPubMedPubMedCentral
4.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed
5.
go back to reference Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J et al (2004) Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med 32:2311–2317CrossRefPubMed Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J et al (2004) Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med 32:2311–2317CrossRefPubMed
6.
go back to reference Broessner G, Helbok R, Lackner P, Mitterberger M, Beer R, Engelhardt K et al (2007) Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients. Crit Care Med 35:2025–2030CrossRefPubMed Broessner G, Helbok R, Lackner P, Mitterberger M, Beer R, Engelhardt K et al (2007) Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients. Crit Care Med 35:2025–2030CrossRefPubMed
7.
go back to reference Kiphuth IC, Schellinger PD, Köhrmann M, Bardutzky J, Lücking H, Kloska S et al (2010) Predictors for good functional outcome after neurocritical care. Crit Care 14:R136CrossRefPubMedPubMedCentral Kiphuth IC, Schellinger PD, Köhrmann M, Bardutzky J, Lücking H, Kloska S et al (2010) Predictors for good functional outcome after neurocritical care. Crit Care 14:R136CrossRefPubMedPubMedCentral
8.
go back to reference Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850CrossRefPubMed Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850CrossRefPubMed
10.
go back to reference Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568CrossRefPubMedPubMedCentral Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568CrossRefPubMedPubMedCentral
11.
go back to reference Authors (1999) Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 27:633–8 Authors (1999) Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 27:633–8
12.
go back to reference Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM et al (2011) Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81:218–224CrossRefPubMedPubMedCentral Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM et al (2011) Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81:218–224CrossRefPubMedPubMedCentral
13.
go back to reference Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed
14.
go back to reference Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003CrossRefPubMed Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003CrossRefPubMed
15.
go back to reference Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466CrossRefPubMed Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466CrossRefPubMed
16.
17.
go back to reference Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818CrossRefPubMed Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818CrossRefPubMed
18.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedPubMedCentral Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedPubMedCentral
19.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed
20.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251CrossRefPubMed Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251CrossRefPubMed
21.
go back to reference Vaquero J, Martínez R, Manrique M (2000) Stereotactic biopsy for brain tumors: is it always necessary? Surg Neurol 53:432–437CrossRefPubMed Vaquero J, Martínez R, Manrique M (2000) Stereotactic biopsy for brain tumors: is it always necessary? Surg Neurol 53:432–437CrossRefPubMed
22.
23.
go back to reference Le Gall JR, Lemeshow S, Saulnier FA (1993) new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier FA (1993) new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMed
24.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRefPubMed
25.
go back to reference Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S (1997) A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 16:965–980CrossRefPubMed Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S (1997) A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 16:965–980CrossRefPubMed
26.
go back to reference Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36CrossRefPubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36CrossRefPubMed
27.
go back to reference Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D et al (2016) Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. J Neurooncol 127:111–117CrossRefPubMed Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D et al (2016) Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. J Neurooncol 127:111–117CrossRefPubMed
28.
go back to reference Arik Y, Leijten FS, Seute T, Robe PA, Snijders TJ (2014) Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis. BMC Neurol 14:152CrossRefPubMedPubMedCentral Arik Y, Leijten FS, Seute T, Robe PA, Snijders TJ (2014) Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis. BMC Neurol 14:152CrossRefPubMedPubMedCentral
29.
go back to reference Vooturi S, Jayalakshmi S, Sahu S, Mohandas S (2014) Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit. Clin Neurol Neurosurg 126:7–10CrossRefPubMed Vooturi S, Jayalakshmi S, Sahu S, Mohandas S (2014) Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit. Clin Neurol Neurosurg 126:7–10CrossRefPubMed
30.
31.
go back to reference Roques S, Parrot A, Lavole A, Ancel PY, Gounant V, Djibre M et al (2009) Six-month prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med 35:2044–2050CrossRefPubMed Roques S, Parrot A, Lavole A, Ancel PY, Gounant V, Djibre M et al (2009) Six-month prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med 35:2044–2050CrossRefPubMed
32.
go back to reference Soares M, Toffart AC, Timsit JF, Burghi G, Irrazábal C, Pattison N et al (2014) Intensive care in patients with lung cancer: a Multinational Study. Ann Oncol 25:1829–1835CrossRefPubMed Soares M, Toffart AC, Timsit JF, Burghi G, Irrazábal C, Pattison N et al (2014) Intensive care in patients with lung cancer: a Multinational Study. Ann Oncol 25:1829–1835CrossRefPubMed
33.
go back to reference Azoulay E, Thiéry G, Chevret S, Moreau D, Darmon M, Bergeron A et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370CrossRef Azoulay E, Thiéry G, Chevret S, Moreau D, Darmon M, Bergeron A et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370CrossRef
34.
go back to reference Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B et al (2007) Prognosis of lung cancer patients with life-threatening complications. Chest 131:840–846CrossRefPubMed Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B et al (2007) Prognosis of lung cancer patients with life-threatening complications. Chest 131:840–846CrossRefPubMed
35.
go back to reference Slatore CG, Cecere LM, Letourneau JL, O’Neil ME, Duckart JP, Wiener RS et al (2012) Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. J Clin Oncol 30:1686–1691CrossRefPubMedPubMedCentral Slatore CG, Cecere LM, Letourneau JL, O’Neil ME, Duckart JP, Wiener RS et al (2012) Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. J Clin Oncol 30:1686–1691CrossRefPubMedPubMedCentral
36.
go back to reference Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E et al (2015) Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 314:1711–1719CrossRefPubMed Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E et al (2015) Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 314:1711–1719CrossRefPubMed
37.
go back to reference Newton HB, Newton C, Pearl D, Davidson T (1994) Swallowing assessment in primary brain tumor patients with dysphagia. Neurology 44:1927–1932CrossRefPubMed Newton HB, Newton C, Pearl D, Davidson T (1994) Swallowing assessment in primary brain tumor patients with dysphagia. Neurology 44:1927–1932CrossRefPubMed
38.
go back to reference Azoulay E, Afessa B (2006) The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 32:3–5CrossRefPubMed Azoulay E, Afessa B (2006) The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 32:3–5CrossRefPubMed
Metadata
Title
Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience
Authors
Maxens Decavèle
Nicolas Weiss
Isabelle Rivals
Hélène Prodanovic
Ahmed Idbaih
Julien Mayaux
Thomas Similowski
Alexandre Demoule
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 11/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8624-7

Other articles of this Issue 11/2017

Journal of Neurology 11/2017 Go to the issue